Alerce Investment Management, L.P.
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 9, 2024), Alerce Investment Management, L.P. reported 5 stock positions worth $95.1 million. Its top holding was Annexon (ANNX) at 55.8% of the portfolio, followed by Akebia Therapeutics (AKBA, 25.4%) and American Well (8.9%). Compared with Q4 2023, it reduced 1. The biggest sale was Akebia Therapeutics (AKBA, shares −19%).
- Most Recent 13F
- Q4 2024
- Location
- Chicago, IL
- CIK
- 0001844002
- Portfolio Value
- $95.1M (Q1 2024)
- SEC Filing
- 0000895345-24-000166 ↗ filed May 9, 2024
Holdings Value
Holdings 5 stocks · $95.1M
| ANNX Annexon Inc. | 55.85% | 7,406,024 | $53.1M | No change |
| AKBA Akebia Therapeutics Inc. | 25.42% | 13,205,119 | $24.2M | Reduce -18.5% |
| AMERICAN WELL CORP | 8.93% | 10,475,717 | $8.5M | No change |
| RNTX Rein Therapeutics Inc. filed as AILERON THERAPEUTICS INC | 5.79% | 830,466 | $5.5M | No change |
| WHWK Whitehawk Therapeutics Inc. filed as AADI BIOSCIENCE INC | 4.01% | 1,630,830 | $3.8M | No change |
Portfolio Sells Q4 2023 → Q1 2024
| AKBA Akebia Therapeutics Inc. | Reduce -18.5% | 25.42% | −1.32 |
Portfolio Buys Q4 2023 → Q1 2024
| None this quarter. | |||